Stock Analysts’ price target changes for Thursday, December 18th:
Acadia Healthcare (NASDAQ:ACHC) had its target price reduced by Mizuho from $22.00 to $17.00. Mizuho currently has a neutral rating on the stock.
AECOM (NYSE:ACM) had its price target trimmed by Truist Financial Corporation from $148.00 to $126.00. They currently have a buy rating on the stock.
Albemarle (NYSE:ALB) had its price target boosted by Mizuho from $110.00 to $132.00. Mizuho currently has a neutral rating on the stock.
American Well (NYSE:AMWL) had its price target lowered by Morgan Stanley from $10.50 to $6.00. Morgan Stanley currently has an equal weight rating on the stock.
Air Products and Chemicals (NYSE:APD) had its price target reduced by Mizuho from $300.00 to $290.00. They currently have an outperform rating on the stock.
Aprea Therapeutics (NASDAQ:APRE) had its target price trimmed by HC Wainwright from $20.00 to $5.00. They currently have a buy rating on the stock.
Ardent Health (NYSE:ARDT) had its target price lowered by Mizuho from $20.00 to $12.00. They currently have an outperform rating on the stock.
Ashland (NYSE:ASH) had its price target boosted by Mizuho from $60.00 to $70.00. The firm currently has an outperform rating on the stock.
AutoZone (NYSE:AZO) had its price target lowered by JPMorgan Chase & Co. from $4,850.00 to $4,100.00. The firm currently has an overweight rating on the stock.
Bank of America (NYSE:BAC) had its target price raised by Truist Financial Corporation from $56.00 to $58.00. Truist Financial Corporation currently has a buy rating on the stock.
Bank of America (NYSE:BAC) had its price target boosted by Oppenheimer Holdings, Inc. from $55.00 to $63.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
Beta Bionics (NASDAQ:BBNX) had its target price raised by Truist Financial Corporation from $32.00 to $37.00. Truist Financial Corporation currently has a buy rating on the stock.
Boston Scientific (NYSE:BSX) had its price target trimmed by Truist Financial Corporation from $130.00 to $120.00. Truist Financial Corporation currently has a buy rating on the stock.
BrightSpring Health Services (NASDAQ:BTSG) had its price target raised by Mizuho from $38.00 to $42.00. They currently have an outperform rating on the stock.
Citigroup (NYSE:C) had its price target increased by Truist Financial Corporation from $112.00 to $123.00. They currently have a buy rating on the stock.
Cabot (NYSE:CBT) had its target price raised by Mizuho from $72.00 to $80.00. They currently have an outperform rating on the stock.
Certara (NASDAQ:CERT) had its price target trimmed by Morgan Stanley from $16.00 to $12.00. Morgan Stanley currently has an equal weight rating on the stock.
CF Industries (NYSE:CF) had its price target reduced by Mizuho from $92.00 to $88.00. The firm currently has a neutral rating on the stock.
Cognex (NASDAQ:CGNX) had its target price lowered by Truist Financial Corporation from $45.00 to $42.00. The firm currently has a hold rating on the stock.
Colgate-Palmolive (NYSE:CL) had its price target raised by JPMorgan Chase & Co. from $87.00 to $88.00. They currently have an overweight rating on the stock.
Cummins (NYSE:CMI) had its target price raised by Truist Financial Corporation from $628.00 to $653.00. Truist Financial Corporation currently has a buy rating on the stock.
Coursera (NYSE:COUR) had its target price lowered by UBS Group AG from $11.00 to $9.00. UBS Group AG currently has a neutral rating on the stock.
Charles River Laboratories International (NYSE:CRL) had its target price increased by Mizuho from $174.00 to $200.00. Mizuho currently has a neutral rating on the stock.
Currys (LON:CURY) had its price target raised by Berenberg Bank from GBX 200 to GBX 210. They currently have a buy rating on the stock.
DuPont de Nemours (NYSE:DD) had its price target boosted by Mizuho from $44.00 to $46.00. They currently have an outperform rating on the stock.
Dynex Capital (NYSE:DX) had its target price raised by Keefe, Bruyette & Woods from $14.00 to $14.50. The firm currently has an outperform rating on the stock.
Elanco Animal Health (NYSE:ELAN) had its target price raised by Morgan Stanley from $18.00 to $22.00. They currently have an equal weight rating on the stock.
e.l.f. Beauty (NYSE:ELF) had its target price cut by JPMorgan Chase & Co. from $137.00 to $103.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Essent Group (NYSE:ESNT) had its price target raised by Keefe, Bruyette & Woods from $71.00 to $73.00. The firm currently has a market perform rating on the stock.
First American Financial (NYSE:FAF) had its target price increased by Keefe, Bruyette & Woods from $79.00 to $81.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
First Horizon (NYSE:FHN) had its price target increased by Truist Financial Corporation from $24.00 to $26.00. The firm currently has a hold rating on the stock.
Freddie Mac (OTCMKTS:FMCC) had its target price lowered by Keefe, Bruyette & Woods from $11.00 to $9.00. They currently have an underperform rating on the stock.
Fidelity National Financial (NYSE:FNF) had its target price raised by Keefe, Bruyette & Woods from $70.00 to $72.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Fortrea (NASDAQ:FTRE) had its price target raised by Mizuho from $11.00 to $13.00. The firm currently has a neutral rating on the stock.
Glaukos (NYSE:GKOS) had its target price raised by Truist Financial Corporation from $120.00 to $145.00. They currently have a buy rating on the stock.
Harbour Energy (LON:HBR) had its price target increased by Canaccord Genuity Group Inc. from GBX 292 to GBX 320. The firm currently has a buy rating on the stock.
HCA Healthcare (NYSE:HCA) had its price target boosted by Mizuho from $505.00 to $520.00. Mizuho currently has an outperform rating on the stock.
Anywhere Real Estate (NYSE:HOUS) had its price target boosted by Keefe, Bruyette & Woods from $11.00 to $13.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Huntsman (NYSE:HUN) had its price target raised by Mizuho from $7.00 to $8.00. The firm currently has an underperform rating on the stock.
Hut 8 (NASDAQ:HUT) had its price target raised by Canaccord Genuity Group Inc. from $54.00 to $62.00. The firm currently has a buy rating on the stock.
Insmed (NASDAQ:INSM) had its target price reduced by Guggenheim from $230.00 to $221.00. They currently have a buy rating on the stock.
Insmed (NASDAQ:INSM) had its target price trimmed by TD Cowen from $269.00 to $241.00. They currently have a buy rating on the stock.
Innovex International (NYSE:INVX) had its price target raised by Piper Sandler from $20.00 to $27.00. They currently have an overweight rating on the stock.
iRhythm Technologies (NASDAQ:IRTC) had its price target reduced by Truist Financial Corporation from $230.00 to $215.00. The firm currently has a buy rating on the stock.
Intuitive Surgical (NASDAQ:ISRG) had its price target raised by Truist Financial Corporation from $620.00 to $650.00. They currently have a buy rating on the stock.
Integer (NYSE:ITGR) had its target price raised by Truist Financial Corporation from $86.00 to $95.00. The firm currently has a buy rating on the stock.
Jabil (NYSE:JBL) had its target price boosted by JPMorgan Chase & Co. from $260.00 to $270.00. The firm currently has an overweight rating on the stock.
JPMorgan Chase & Co. (NYSE:JPM) had its target price increased by Truist Financial Corporation from $319.00 to $330.00. The firm currently has a hold rating on the stock.
Lennar (NYSE:LEN) had its target price trimmed by Keefe, Bruyette & Woods from $125.00 to $115.00. They currently have a market perform rating on the stock.
Lennar (NYSE:LEN) had its target price cut by JPMorgan Chase & Co. from $115.00 to $80.00. The firm currently has an underweight rating on the stock.
Lantheus (NASDAQ:LNTH) had its target price boosted by Truist Financial Corporation from $80.00 to $82.00. The firm currently has a buy rating on the stock.
Lam Research (NASDAQ:LRCX) had its price target raised by B. Riley from $180.00 to $195.00. B. Riley currently has a buy rating on the stock.
LuxExperience B.V. (NYSE:LUXE) had its target price boosted by JPMorgan Chase & Co. from $8.00 to $9.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Mercantile Bank (NASDAQ:MBWM) had its price target increased by Hovde Group from $53.00 to $56.00. They currently have an outperform rating on the stock.
Medtronic (NYSE:MDT) had its target price cut by Truist Financial Corporation from $110.00 to $107.00. They currently have a hold rating on the stock.
AG Mortgage Investment Trust (NYSE:MITT) had its target price boosted by Keefe, Bruyette & Woods from $8.50 to $9.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Mosaic (NYSE:MOS) had its target price reduced by Mizuho from $31.00 to $28.00. The firm currently has a neutral rating on the stock.
MGIC Investment (NYSE:MTG) had its price target increased by Keefe, Bruyette & Woods from $27.00 to $28.00. They currently have a market perform rating on the stock.
MasTec (NYSE:MTZ) had its price target boosted by Truist Financial Corporation from $253.00 to $270.00. They currently have a buy rating on the stock.
Micron Technology (NASDAQ:MU) had its target price increased by UBS Group AG from $295.00 to $300.00. UBS Group AG currently has a buy rating on the stock.
Micron Technology (NASDAQ:MU) had its price target boosted by Wells Fargo & Company from $300.00 to $335.00. The firm currently has an overweight rating on the stock.
Micron Technology (NASDAQ:MU) had its price target raised by TD Cowen from $275.00 to $300.00. The firm currently has a buy rating on the stock.
Micron Technology (NASDAQ:MU) had its price target boosted by Piper Sandler from $200.00 to $275.00. Piper Sandler currently has an overweight rating on the stock.
Micron Technology (NASDAQ:MU) had its target price raised by KeyCorp from $215.00 to $325.00. KeyCorp currently has an overweight rating on the stock.
Micron Technology (NASDAQ:MU) had its price target raised by JPMorgan Chase & Co. from $220.00 to $350.00. They currently have an overweight rating on the stock.
Micron Technology (NASDAQ:MU) had its target price boosted by Wolfe Research from $300.00 to $350.00. The firm currently has an outperform rating on the stock.
Nutrien (NYSE:NTR) had its target price boosted by Mizuho from $61.00 to $65.00. They currently have a neutral rating on the stock.
Penumbra (NYSE:PEN) had its price target boosted by Truist Financial Corporation from $312.00 to $370.00. The firm currently has a buy rating on the stock.
PennyMac Financial Services (NYSE:PFSI) had its target price boosted by Keefe, Bruyette & Woods from $138.00 to $143.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Procter & Gamble (NYSE:PG) had its target price trimmed by JPMorgan Chase & Co. from $165.00 to $157.00. They currently have a neutral rating on the stock.
Progressive (NYSE:PGR) had its price target increased by Keefe, Bruyette & Woods from $246.00 to $250.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Progressive (NYSE:PGR) had its target price cut by BMO Capital Markets from $256.00 to $253.00. They currently have a market perform rating on the stock.
Parker-Hannifin (NYSE:PH) had its target price increased by Truist Financial Corporation from $977.00 to $1,097.00. Truist Financial Corporation currently has a buy rating on the stock.
The PNC Financial Services Group (NYSE:PNC) had its target price increased by Truist Financial Corporation from $210.00 to $229.00. The firm currently has a hold rating on the stock.
Insulet (NASDAQ:PODD) had its price target reduced by Truist Financial Corporation from $412.00 to $390.00. The firm currently has a buy rating on the stock.
PROCEPT BioRobotics (NASDAQ:PRCT) had its price target trimmed by Truist Financial Corporation from $50.00 to $47.00. Truist Financial Corporation currently has a buy rating on the stock.
Primo Brands (NYSE:PRMB) had its price target cut by JPMorgan Chase & Co. from $23.00 to $21.00. They currently have an overweight rating on the stock.
Radian Group (NYSE:RDN) had its target price increased by Keefe, Bruyette & Woods from $40.00 to $41.00. They currently have a market perform rating on the stock.
Rocket Companies (NYSE:RKT) had its target price boosted by Keefe, Bruyette & Woods from $18.00 to $20.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
RPM International (NYSE:RPM) had its price target lowered by Mizuho from $138.00 to $128.00. Mizuho currently has an outperform rating on the stock.
RPM International (NYSE:RPM) had its price target lowered by UBS Group AG from $127.00 to $119.00. The firm currently has a neutral rating on the stock.
Southern Copper (NYSE:SCCO) had its price target boosted by JPMorgan Chase & Co. from $114.50 to $119.50. The firm currently has a neutral rating on the stock.
SolarEdge Technologies (NASDAQ:SEDG) had its target price reduced by The Goldman Sachs Group, Inc. from $36.00 to $31.00. They currently have a neutral rating on the stock.
Surgery Partners (NASDAQ:SGRY) had its price target reduced by Mizuho from $22.00 to $19.00. They currently have an outperform rating on the stock.
Sherwin-Williams (NYSE:SHW) had its price target lowered by Mizuho from $400.00 to $390.00. The firm currently has an outperform rating on the stock.
SiBone (NASDAQ:SIBN) had its target price increased by Truist Financial Corporation from $21.00 to $23.00. They currently have a buy rating on the stock.
Society Pass (NASDAQ:SOPA) had its price target boosted by Ascendiant Capital Markets from $22.00 to $22.50. Ascendiant Capital Markets currently has a buy rating on the stock.
SPX Technologies (NYSE:SPXC) had its price target raised by Truist Financial Corporation from $215.00 to $216.00. Truist Financial Corporation currently has a hold rating on the stock.
Stewart Information Services (NYSE:STC) had its target price boosted by Keefe, Bruyette & Woods from $78.00 to $81.00. They currently have a market perform rating on the stock.
Savara (NASDAQ:SVRA) had its price target boosted by Wells Fargo & Company from $7.00 to $9.00. They currently have an overweight rating on the stock.
Stryker (NYSE:SYK) had its target price cut by Truist Financial Corporation from $400.00 to $392.00. The firm currently has a hold rating on the stock.
BBB Foods (NYSE:TBBB) had its target price increased by The Goldman Sachs Group, Inc. from $30.00 to $34.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Tesla (NASDAQ:TSLA) had its target price raised by CICC Research from $450.00 to $500.00. CICC Research currently has an outperform rating on the stock.
UWM (NYSE:UWMC) had its target price increased by Keefe, Bruyette & Woods from $6.50 to $6.75. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
V.F. (NYSE:VFC) had its price target boosted by Needham & Company LLC from $19.00 to $21.00. Needham & Company LLC currently has a buy rating on the stock.
Vital Farms (NASDAQ:VITL) had its price target lowered by BMO Capital Markets from $60.00 to $50.00. They currently have an outperform rating on the stock.
Vital Farms (NASDAQ:VITL) had its price target trimmed by TD Cowen from $59.00 to $44.00. TD Cowen currently has a buy rating on the stock.
Controladora Vuela Compania de Aviacion (NYSE:VLRS) had its target price increased by Barclays PLC from $7.00 to $9.00. They currently have an equal weight rating on the stock.
VolitionRx (NYSE:VNRX) had its target price trimmed by D. Boral Capital from $5.00 to $3.00. The firm currently has a buy rating on the stock.
Weatherford International (NASDAQ:WFRD) had its price target raised by Piper Sandler from $80.00 to $95.00. They currently have an overweight rating on the stock.
Receive News & Ratings for Acadia Healthcare Company Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc and related companies with MarketBeat.com's FREE daily email newsletter.
